burping glp 1 “Sulfur burps” in patients on GLP-1 therapies may be more than a minor side effect. Experts note these symptoms can reflect underlying gastrointestinal changes linked to the drugs’ mechanism of semaglutide diarrhea and burping sulfur

For example, a patient stepping down from 2 mg of semaglutide weekly might see 0.25 mg as a microdose, even though it is the standard approved starting dose

doi: 10.1016/j.jddst.2016.06.007 176

Concurrent medications : Patients taking multiple medications should consider potential interactions

The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis

Some patients may continue treatment, some may reduce dose, and some may transition off with close monitoring

This combination has not been studied as a protocol and should only be explored under medical supervision